|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Operating activities: | |||||
| Net loss for the year | |||||
| Adjustments for: | |||||
| Depreciation and amortization | |||||
| Deferred gain amortization | |||||
| Impairment loss on trade receivables | |||||
| Inventory (reversal) impairment and onerous contracts provision adjustments | |||||
| Unrealized (gain) loss on forward contracts | |||||
| Equity in loss of investment in joint venture and associates | |||||
| Net (increase) decrease in fair value of investments | |||||
| Gain on sale of assets | |||||
| De-recognition of lease | |||||
| Impairment charges on property, plant and equipment | |||||
| Impairment charges on intangible assets | |||||
| Impairment charges on goodwill | |||||
| Recovery on settlement of contingent consideration | |||||
| Impairment charges on equity-accounted investment | |||||
| Accretion on decommissioning liabilities | |||||
| Employee future benefits and plan contributions | |||||
| Employee future benefits plan contributions | |||||
| Share-based compensation | |||||
| Deferred income tax recovery | |||||
| Total adjustments | |||||
| Changes in non-cash working capital: | |||||
| Trade and other receivables | |||||
| Inventories | |||||
| Prepaid expenses and other current assets | |||||
| Trade and other payables | |||||
| Deferred revenue | |||||
| Warranty provision | |||||
| Changes in non-cash working capital: | |||||
| Cash used in operating activities | |||||
| Investing activities: | |||||
| Net increase in short-term investments | |||||
| Contributions to long-term investments | |||||
| Recovery of contributions to long-term investments | |||||
| Additions to property, plant and equipment | |||||
| Investment in intangible assets | |||||
| Investment in joint venture and associates | |||||
| Proceeds on sale of assets | |||||
| Consideration paid related to acquisition | |||||
| Cash used in investing activities | |||||
| Financing activities: | |||||
| Principal payments of lease liabilities | |||||
| Net proceeds on issuance of share capital from share option exercises | |||||
| Net proceeds on defined benefit obligation settlement | |||||
| Cash used in financing activities | |||||
| Effect of exchange rate fluctuations on cash and cash equivalents held | |||||
| Decrease in cash and cash equivalents | |||||
| Cash and cash equivalents, beginning of year | |||||
| Cash and cash equivalents, end of year | |||||
Loading...